Cláudia Azevedo (i3S – Instituto de Investigação e Inovação em Saúde; INEB - Instituto Nacional de Engenharia Biomédica, University of Porto, Porto, Portugal; Instituto de Ciências Biomédicas Abel Salazar, University of Porto, Porto, Portugal), Jeannette Nilsen (Department of Immunology, Centre for Immune Regulation (CIR), Oslo University Hospital Rikshospitalet and University of Oslo, Oslo, Norway; Institute of Clinical Medicine, University of Oslo, Oslo, Norway), Algirdas Grevys (Centre for Immune Regulation (CIR) and Department of Biosciences, University of Oslo, N-0316 Oslo, Norway; CIR and Department of Immunology, University of Oslo and Oslo University Hospital Rikshospitalet, PO Box 4950, N-0424, Oslo, Norway), Stian Foss (Centre for Immune Regulation (CIR), Department of Biosciences, University of Oslo, N-0316, Oslo, Norway; Department of Immunology and CIR, Oslo University Hospital, Rikshospitalet, University of Oslo, N-0372, Oslo, Norway), Jan Terje Andersen (Department of Immunology, Centre for Immune Regulation (CIR), Oslo University Hospital Rikshospitalet and University of Oslo, Oslo, Norway; Department of Biosciences, University of Oslo, Norway), Bruno Sarmento (i3S – Instituto de Investigação e Inovação em Saúde, Universidade do Porto, Porto, Portugal; CESPU, Instituto de Investigação e Formação Avançada em Ciências e Tecnologias da Saúde & Instituto Universitário de Ciências da Saúde, Gandra, Portugal)